Role of Neural Progenitor Cells in the Development of Neonatal Hydrocephalus

神经祖细胞在新生儿脑积水发展中的作用

基本信息

  • 批准号:
    8657125
  • 负责人:
  • 金额:
    $ 32.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-01 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Neonatal hydrocephalus is a common developmental anomaly affecting the human nervous system with an estimated incidence of 1 to 3 per 1,000 live births creating an estimated healthcare burden of 2 billion dollars annually. Hydrocephalus leads to the expansion of cerebral ventricles and is associated with significant morbidity and mortality with mortality rates as high as 35%. A significant portion of neonatal hydrocephalus is idiopathic in nature. The major goal of this proposal is the identification of molecular mechanisms underlying hydrocephalus for the purpose of developing novel medical treatments. This goal will be pursued by utilizing mouse models of human ciliopathies. Ciliopathies are a group of disorders that display overlapping phenotypes with a common etiology of cilia defects. Ciliopathy models have described that develop hydrocephalus as a result of altered ependymal cilia beat mechanics resulting in abnormal flow of CSF. In this proposal, we challenge the notion that motile cilia defects are the sole cause of hydrocephalus in ciliopathy models with our central hypothesis that abnormal development of specific neural progenitor cells during early development plays a major role in hydrocephalus. The central hypothesis and the specific aims of this proposal are based on strong preliminary data. In specific aim 1, we will build upon strong preliminary data that show that abnormal development of specific neural progenitor cells lead to hydrocephalus in a specific mouse model of the human disorder, Bardet-Biedl Syndrome (BBS). We will determine the specific neuroprogenitor cells involved in hydrocephalus, and determine the defective signaling pathways in the neuroprogenitor cells that contribute to hydrocephalus. In specific aim 2, we will determine whether similar mechanisms apply to other ciliopathy mouse models. In specific aim 3, we will investigate the potential for modifying the hydrocephalic phenotype in ciliopathy mouse models utilizing pharmaceuticals and genetic methods to manipulate signaling pathways identified in Aim 1 and Aim 2. Successful completion of the research outlined in this application will advance the understanding of cilia dysfunction and cilia related diseases in general, especially the molecular mechanism underlying the pathogenesis of hydrocephalus. The results of this study will have significant implications for therapeutic treatment of neonatal hydrocephalus.
描述(由申请方提供):新生儿脑积水是一种影响人类神经系统的常见发育异常,估计发病率为1 - 3/1000例活产,每年造成的医疗负担估计为20亿美元。脑积水导致脑室扩张,并与显著的发病率和死亡率相关,死亡率高达35%。很大一部分新生儿脑积水是特发性的。该提案的主要目标是确定脑积水的分子机制,以开发新的医学治疗方法。这一目标将通过利用人类纤毛病变的小鼠模型来实现。纤毛病是一组表现出重叠表型的疾病,其共同病因是纤毛缺陷。纤毛病模型已经描述了由于室管膜纤毛搏动机制改变导致CSF的异常流动而发展脑积水。在这个提议中,我们挑战了这样一种观点,即运动纤毛缺陷是纤毛病变模型中脑积水的唯一原因, 早期发育过程中特定神经前体细胞的异常发育在脑积水中起主要作用的假说。这项建议的核心假设和具体目标是以强有力的初步数据为基础的。在具体目标1中,我们将建立在强大的 初步数据显示,在人类疾病Bardet-Biedl综合征(BBS)的特定小鼠模型中,特定神经祖细胞的异常发育导致脑积水。我们将确定参与脑积水的特定神经前体细胞,并确定导致脑积水的神经前体细胞中有缺陷的信号通路。在具体目标2中,我们将确定类似的机制是否适用于其他纤毛病小鼠模型。在具体目标3中,我们将研究利用药物和遗传学方法来操纵目标1和目标2中鉴定的信号传导途径,从而改变纤毛病小鼠模型中脑积水表型的潜力。成功完成本申请中概述的研究将促进对纤毛功能障碍和纤毛 相关疾病,特别是脑积水发病机制的分子机制。本研究的结果将对新生儿脑积水的治疗具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Val C. Sheffield其他文献

Three autosomal dominant corneal dystrophies map to chromosome 5q
三种常染色体显性遗传性角膜营养不良定位于 5q 染色体
  • DOI:
    10.1038/ng0194-47
  • 发表时间:
    1994-01-01
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Edwin M. Stone;William D. Mathers;George O.D. Rosenwasser;Edward J. Holland;Robert Folberg;Jay H. Krachmer;Brian E. Nichols;Peter D. Gorevic;Chris M. Taylor;Luan M. Streb;Jill A. Fishbaugh;Thomas E. Daley;Brian M. Sucheski;Val C. Sheffield
  • 通讯作者:
    Val C. Sheffield
De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis
与莱伯先天性黑蒙症相关的 CRX 同源框基因的从头突变
  • DOI:
    10.1038/ng0498-311
  • 发表时间:
    1998-04-01
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Carol L. Freund;Qing-Ling Wang;Shiming Chen;Brenda L. Muskat;Carmella D. Wiles;Val C. Sheffield;Samuel G. Jacobson;Roderick R. Mclnnes;Donald J. Zack;Edwin M. Stone
  • 通讯作者:
    Edwin M. Stone
Gene therapy and gene correction: targets, progress, and challenges for treating human diseases
基因治疗和基因校正:治疗人类疾病的靶点、进展和挑战
  • DOI:
    10.1038/s41434-020-00197-8
  • 发表时间:
    2020-10-09
  • 期刊:
  • 影响因子:
    4.500
  • 作者:
    Matthew R. Cring;Val C. Sheffield
  • 通讯作者:
    Val C. Sheffield
Identification of the gene that, when mutated, causes the human obesity syndrome BBS4
对导致人类肥胖综合征 BBS4 的基因突变基因的鉴定
  • DOI:
    10.1038/88925
  • 发表时间:
    2001-06-01
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Kirk Mykytyn;Terry Braun;Rivka Carmi;Neena B. Haider;Charles C. Searby;Mythreyi Shastri;Gretel Beck;Alan F. Wright;Alessandro Iannaccone;Khalil Elbedour;Ruth Riise;Alfonso Baldi;Annick Raas-Rothschild;Susan W. Gorman;David M. Duhl;Samuel G. Jacobson;Thomas Casavant;Edwin M. Stone;Val C. Sheffield
  • 通讯作者:
    Val C. Sheffield
A denaturing gradient gel electrophoresis assay for sensitive detection of p53 mutations
  • DOI:
    10.1007/bf00230217
  • 发表时间:
    1993-03-01
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    John S. Beck;Anne E. Kwitek;Phillip H. Cogen;Andrew K. Metzger;Geoffrey M. Duyk;Val C. Sheffield
  • 通讯作者:
    Val C. Sheffield

Val C. Sheffield的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Val C. Sheffield', 18)}}的其他基金

Evaluation of Orthogonally Oriented Electromagnetic Fields to Stabilize ROS, Induce DNA damage and Improve Survival in Non-Small Cell Lung Cancer
正交定向电磁场稳定 ROS、诱导 DNA 损伤和提高非小细胞肺癌生存率的评估
  • 批准号:
    10290446
  • 财政年份:
    2021
  • 资助金额:
    $ 32.7万
  • 项目类别:
Evaluation of Orthogonally Oriented Electromagnetic Fields to Stabilize ROS, Induce DNA damage and Improve Survival in Non-Small Cell Lung Cancer
正交定向电磁场稳定 ROS、诱导 DNA 损伤和提高非小细胞肺癌生存率的评估
  • 批准号:
    10447184
  • 财政年份:
    2021
  • 资助金额:
    $ 32.7万
  • 项目类别:
Multidisciplinary Investigations in Visual Science
视觉科学的多学科研究
  • 批准号:
    10271728
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10271729
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
Multidisciplinary Investigations in Visual Science
视觉科学的多学科研究
  • 批准号:
    9762933
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10488229
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
Multidisciplinary Investigations in Visual Science
视觉科学的多学科研究
  • 批准号:
    10488228
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
Multidisciplinary Investigations in Visual Science
视觉科学的多学科研究
  • 批准号:
    9334864
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
Multidisciplinary Investigations in Visual Science
视觉科学的多学科研究
  • 批准号:
    10663388
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10663389
  • 财政年份:
    2016
  • 资助金额:
    $ 32.7万
  • 项目类别:

相似海外基金

Using a patient-derived fibroblast ciliation assay to perform high throughput drug screen and candidate therapeutic compound validation for Bardet-Biedl syndrome (BBS)
使用患者来源的成纤维细胞纤毛检测对 Bardet-Biedl 综合征 (BBS) 进行高通量药物筛选和候选治疗化合物验证
  • 批准号:
    449358
  • 财政年份:
    2020
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Studentship Programs
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8918625
  • 财政年份:
    2012
  • 资助金额:
    $ 32.7万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8534137
  • 财政年份:
    2012
  • 资助金额:
    $ 32.7万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8340877
  • 财政年份:
    2012
  • 资助金额:
    $ 32.7万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8708874
  • 财政年份:
    2012
  • 资助金额:
    $ 32.7万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    9235611
  • 财政年份:
    2012
  • 资助金额:
    $ 32.7万
  • 项目类别:
Towards a structural understanding of childhood obesity in Bardet-Biedl syndrome
对 Bardet-Biedl 综合征儿童肥胖的结构性理解
  • 批准号:
    8146164
  • 财政年份:
    2009
  • 资助金额:
    $ 32.7万
  • 项目类别:
Towards a structural understanding of childhood obesity in Bardet-Biedl syndrome
对 Bardet-Biedl 综合征儿童肥胖的结构性理解
  • 批准号:
    7753399
  • 财政年份:
    2009
  • 资助金额:
    $ 32.7万
  • 项目类别:
Towards a structural understanding of childhood obesity in Bardet-Biedl syndrome
对 Bardet-Biedl 综合征儿童肥胖的结构性理解
  • 批准号:
    7938614
  • 财政年份:
    2009
  • 资助金额:
    $ 32.7万
  • 项目类别:
Small GTPase ARL6 segregates with Bardet-Biedl Syndrome 3 (BBS3) and may be required for cell cycle progession
小 GTP 酶 ARL6 与 Bardet-Biedl 综合征 3 (BBS3) 分离,并且可能是细胞周期进展所必需的
  • 批准号:
    361511-2008
  • 财政年份:
    2008
  • 资助金额:
    $ 32.7万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了